Vimarsana
Biggest News Aggregation in the World

Page 26 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

340B Program May Be Reducing Biosimilar Uptake - Vimarsana News

340B Program May Be Reducing Biosimilar Uptake

New research has found the 340B program is slowing uptake of biosimilars by incentivizing use of more expensive biologics.

Source: ajmc.com
Major Shift in Best Price Proposed in Grab Bag of MDRP Reforms | King & Spalding - Vimarsana News

Major Shift in Best Price Proposed in Grab Bag of MDRP Reforms | King & Spalding

The title of CMS’s May 26 proposed rule, “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the MDRP,” buries the lede. Amid twenty Medicaid Drug...

Losing Discount Drug Program Would Cost Hospitals, Health Centers Millions - Vimarsana News

Losing Discount Drug Program Would Cost Hospitals, Health Centers Millions

The 340B Drug Pricing Program allows community health centers and about 50 qualified hospitals in Arkansas to buy discounted prescription drugs from manufacturers, using the money to improve patient care.

CMS Proposes Significant Changes to Medicaid Drug Rebate Program | Hogan Lovells - Vimarsana News

CMS Proposes Significant Changes to Medicaid Drug Rebate Program | Hogan Lovells

On May 23, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Misclassification of Drugs, Program Administration and Program Integrity Updates...

Big Pharma Uses Fuzzy Math to Discredit Discount Drug Program - Vimarsana News

Big Pharma Uses Fuzzy Math to Discredit Discount Drug Program

For 340B, a program granting cheaper medicines to nonprofit healthcare patients, drug industry innumeracy is only rivaled by its greed.